round button
Leave a message

Asia-Pacific Vagus Nerve Stimulation Market – Industry Trends and Forecast to 2029

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Asia-Pacific Vagus Nerve Stimulation Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Nov 2022
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 202
  • No of Figures: 44

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA PACIFIC VAGUS NERVE STIMULATION MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 LIFELINE CURVE , BY PRODUCT TYPE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

4.3 KEY STRATEGIC INITIATIVES

5 REGULATIONS OF ASIA PACIFIC VAGUS NERVE STIMULATION MARKET

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE AND INCIDENCE OF NEUROLOGICAL DISORDERS

6.1.2 INNOVATIVE NON-INVASIVE VAGUS NERVE STIMULATION DEVICES INTRODUCED TO MEET DEMAND

6.1.3 RISE IN PRODUCT APPROVALS

6.1.4 PRODUCT DEVELOPMENT IN RECENT YEARS

6.2 RESTRAINTS

6.2.1 HIGH MAINTENANCE AND DEVICE COSTS TO RESTRAIN ADOPTION OF VAGUS NERVE STIMULATORS

6.2.2 RISE IN PRODUCT RECALL

6.2.3 UNFAVORABLE REIMBURSEMENT POLICIES

6.3 OPPORTUNITIES

6.3.1 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS

6.3.2 RISING GOVERNMENT INITIATIVES FOR NEUROLOGICAL DISEASE

6.4 CHALLENGES

6.4.1 RISKS ASSOCIATED WITH THE IMPLANTATION OF THESE DEVICES

6.4.2 LACK OF SKILLED HEALTHCARE PROFESSIONALS

6.4.3 STRINGENT REGULATIONS FOR APPROVAL OF MEDICAL DEVICES

7 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 IMPLANTABLE VNS DEVICE

7.3 EXTERNAL VNS DEVICE

8 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL

8.1 OVERVIEW

8.2 METALLIC

8.3 POLYMERIC

8.4 CERAMICS

9 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 EPILEPTIC SEIZURES

9.2.1 IMPLANTABLE VNS DEVICE

9.2.2 EXTERNAL VNS DEVICE

9.3 DEPRESSION AND ANXIETY

9.3.1 IMPLANTABLE VNS DEVICE

9.3.2 EXTERNAL VNS DEVICE

9.4 PAIN MANAGEMENT

9.4.1 IMPLANTABLE VNS DEVICE

9.4.2 EXTERNAL VNS DEVICE

9.5 OBESITY MANAGEMENT

9.5.1 IMPLANTABLE VNS DEVICE

9.5.2 EXTERNAL VNS DEVICE

9.6 OTHERS

10 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE

10.1 OVERVIEW

10.2 ADULTS

10.2.1 IMPLANTABLE VNS DEVICES

10.2.2 EXTERNAL VNS DEVICES

10.3 GERIATRIC

10.3.1 IMPLANTABLE VNS DEVICES

10.3.2 EXTERNAL VNS DEVICES

10.4 PEDIATRIC

10.4.1 IMPLANTABLE VNS DEVICES

10.4.2 EXTERNAL VNS DEVICES

11 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY END USER

11.1 OVERVIEW

11.2 SPECIALTY CENTERS

11.3 HOSPITALS

11.4 AMBULATORY SURGICAL CENTERS (ASCS)

11.5 OTHERS

12 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 DIRECT TENDER

12.3 RETAIL SALES

12.4 OTHERS

13 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY REGION

13.1 ASIA-PACIFIC

13.1.1 CHINA

13.1.2 JAPAN

13.1.3 SOUTH KOREA

13.1.4 INDIA

13.1.5 AUSTRALIA

13.1.6 SINGAPORE

13.1.7 THAILAND

13.1.8 MALAYSIA

13.1.9 INDONESIA

13.1.10 PHILIPPINES

13.1.11 REST OF ASIA-PACIFIC

14 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 ELECTROCORE, INC.

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 LIVANOVA PLC

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 MEDTRONIC

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 SETPOINT MEDICAL

16.4.1 COMPANY SNAPSHOT

16.4.2 COMPANY SHARE ANALYSIS

16.4.3 PRODUCT PORTFOLIO

16.4.4 RECENT DEVELOPMENTS

16.5 TVNS TECHNOLOGIES GMBH

16.5.1 COMPANY SNAPSHOT

16.5.2 COMPANY SHARE ANALYSIS

16.5.3 PRODUCT PORTFOLIO

16.5.4 RECENT DEVELOPMENT

16.6 NEUROPIX COMPANY LTD.

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 BRAIN CONTROL CO. LTD

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 CIRTEC

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 MICROTRANSPONDER INC.

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 PARASYM LTD

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENT

16.11 RESHAPE LIFESCIENCES INC. (2021)

16.11.1 COMPANY SNAPSHOT

16.11.2 REVENUE ANALYSIS

16.11.3 PRODUCT PORTFOLIO

16.11.4 RECENT DEVELOPMENT

16.12 SOTERIX MEDICAL INC.

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 ASIA PACIFIC IMPLANTABLE VNS DEVICES IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 ASIA PACIFIC EXTERNAL VNS DEVICES IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 5 ASIA PACIFIC METALLIC IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 ASIA PACIFIC POLYMERIC IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 ASIA PACIFIC CERAMICS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 9 ASIA PACIFIC EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 ASIA PACIFIC EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 11 ASIA PACIFIC DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 ASIA PACIFIC DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 13 ASIA PACIFIC PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 ASIA PACIFIC PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 15 ASIA PACIFIC OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 ASIA PACIFIC OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 17 ASIA PACIFIC OTHERS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 19 ASIA PACIFIC ADULTS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 ASIA PACIFIC ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 21 ASIA PACIFIC GERIATRICS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 ASIA PACIFIC GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 23 ASIA PACIFIC PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 ASIA PACIFIC PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 25 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 26 ASIA PACIFIC SPECIALTY CENTERS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 ASIA PACIFIC HOSPITALS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 ASIA PACIFIC AMBULATORY SURGICAL CENTERS (ASCS) IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 ASIA PACIFIC OTHERS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 31 ASIA PACIFIC DIRECT TENDER IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 ASIA PACIFIC RETAIL SALES IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 ASIA PACIFIC OTHERS IN VAGUS NERVE STIMULATION MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 35 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 36 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 37 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 38 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 39 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 40 ASIA-PACIFIC EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 41 ASIA-PACIFIC DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 42 ASIA-PACIFIC PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 43 ASIA-PACIFIC OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 44 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 45 ASIA-PACIFIC ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 46 ASIA-PACIFIC GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 47 ASIA-PACIFIC PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 48 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 49 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 50 CHINA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 51 CHINA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 52 CHINA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 53 CHINA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 54 CHINA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 55 CHINA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 56 CHINA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 57 CHINA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 58 CHINA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 59 CHINA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 60 CHINA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 61 CHINA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 62 CHINA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 63 CHINA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 64 CHINA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 65 JAPAN VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 66 JAPAN VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 67 JAPAN VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 68 JAPAN VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 69 JAPAN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 70 JAPAN EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 71 JAPAN DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 72 JAPAN PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 73 JAPAN OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 74 JAPAN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 75 JAPAN ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 76 JAPAN GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 77 JAPAN PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 78 JAPAN VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 79 JAPAN VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 80 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 81 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 82 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 83 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 84 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 85 SOUTH KOREA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 86 SOUTH KOREA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 87 SOUTH KOREA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 88 SOUTH KOREA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 89 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 90 SOUTH KOREA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 91 SOUTH KOREA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 92 SOUTH KOREA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 93 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 94 SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 95 INDIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 96 INDIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 97 INDIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 98 INDIA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 99 INDIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 100 INDIA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 101 INDIA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 102 INDIA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 103 INDIA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 104 INDIA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 105 INDIA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 106 INDIA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 107 INDIA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 108 INDIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 109 INDIA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 110 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 111 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 112 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 113 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 114 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 115 AUSTRALIA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 116 AUSTRALIA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 117 AUSTRALIA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 118 AUSTRALIA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 119 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 120 AUSTRALIA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 121 AUSTRALIA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 122 AUSTRALIA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 123 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 124 AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 125 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 126 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 127 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 128 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 129 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 130 SINGAPORE EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 131 SINGAPORE DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 132 SINGAPORE PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 133 SINGAPORE OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 134 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 135 SINGAPORE ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 136 SINGAPORE GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 137 SINGAPORE PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 138 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 139 SINGAPORE VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 140 THAILAND VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 141 THAILAND VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 142 THAILAND VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 143 THAILAND VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 144 THAILAND VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 145 THAILAND EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 146 THAILAND DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 147 THAILAND PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 148 THAILAND OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 149 THAILAND VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 150 THAILAND ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 151 THAILAND GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 152 THAILAND PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 153 THAILAND VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 154 THAILAND VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 155 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 156 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 157 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 158 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 159 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 160 MALAYSIA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 161 MALAYSIA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 162 MALAYSIA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 163 MALAYSIA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 164 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 165 MALAYSIA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 166 MALAYSIA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 167 MALAYSIA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 168 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 169 MALAYSIA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 170 INDONESIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 171 INDONESIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 172 INDONESIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 173 INDONESIA VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 174 INDONESIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 175 INDONESIA EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 176 INDONESIA DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 177 INDONESIA PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 178 INDONESIA OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 179 INDONESIA VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 180 INDONESIA ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 181 INDONESIA GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 182 INDONESIA PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 183 INDONESIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 184 INDONESIA VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 185 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 186 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 187 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 188 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL, 2020-2029 (USD MILLION)

TABLE 189 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 190 PHILIPPINES EPILEPTIC SEIZURES IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 191 PHILIPPINES DEPRESSION AND ANXIETY IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 192 PHILIPPINES PAIN MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 193 PHILIPPINES OBESITY MANAGEMENT IN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 194 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 195 PHILIPPINES ADULTS IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 196 PHILIPPINES GERIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 197 PHILIPPINES PEDIATRIC IN VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 198 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 199 PHILIPPINES VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 200 REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 201 REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME)

TABLE 202 REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

List of Figure

FIGURE 1 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: SEGMENTATION

FIGURE 2 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: DATA TRIANGULATION

FIGURE 3 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: DROC ANALYSIS

FIGURE 4 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: DBMR MARKET POSITION GRID

FIGURE 8 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: SEGMENTATION

FIGURE 11 THE GROWING DEMAND FOR INNOVATIVE NON–INVASIVE VAGUS STIMULATION DEVICES AND THE INCREASED PREVALENCE OF NEUROLOGICAL DISORDERS ARE EXPECTED TO DRIVE THE ASIA PACIFIC VAGUS NERVE STIMULATION MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 IMPLANTABLE VNS DEVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC VAGUS NERVE STIMULATION MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC VAGUS NERVE STIMULATION MARKET

FIGURE 14 INCIDENCE OF ADULT-ONSET BRAIN DISORDERS IN THE U.S. IN 2021

FIGURE 15 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE, 2021

FIGURE 16 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)

FIGURE 17 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE, CAGR (2022-2029)

FIGURE 18 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 19 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY BIOMATERIAL, 2021

FIGURE 20 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY BIOMATERIAL, 2022-2029 (USD MILLION)

FIGURE 21 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY BIOMATERIAL, CAGR (2022-2029)

FIGURE 22 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY BIOMATERIAL, LIFELINE CURVE

FIGURE 23 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY APPLICATION, 2021

FIGURE 24 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 25 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 26 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 27 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY PATIENT TYPE, 2021

FIGURE 28 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY PATIENT TYPE, 2022-2029 (USD MILLION)

FIGURE 29 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY PATIENT TYPE, CAGR (2022-2029)

FIGURE 30 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY PATIENT TYPE, LIFELINE CURVE

FIGURE 31 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY END USER, 2021

FIGURE 32 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 33 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY END USER, CAGR (2022-2029)

FIGURE 34 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY END USER, LIFELINE CURVE

FIGURE 35 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 36 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 37 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 38 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 39 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET: SNAPSHOT (2021)

FIGURE 40 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021)

FIGURE 41 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2022 & 2029)

FIGURE 42 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET: BY COUNTRY (2021 & 2029)

FIGURE 43 ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET: BY PRODUCT TYPE (2022 - 2029)

FIGURE 44 ASIA PACIFIC VAGUS NERVE STIMULATION MARKET: COMPANY SHARE 2021 (%)

Frequently Asked Questions

The market is segmented based on Asia-Pacific Vagus Nerve Stimulation Market, By Product Type (Implantable VNS Devices and External VNS Devices), Biomaterial (Ceramics, Metallic, and Polymeric), Application (Pain Management, Epileptic Seizures, Obesity Management, Depression and Anxiety, and Others), Patient Type (Adults, Pediatric, and Geriatric), End User (Hospitals, Ambulatory Surgery Centres, Specialty Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) industry trends and forecast to 2029. .
The Asia Pacific Vagus Nerve Stimulation Market size was valued at USD 145.53 USD Million in 2021.
The Asia Pacific Vagus Nerve Stimulation Market is projected to grow at a CAGR of 14% during the forecast period of 2022 to 2029.
The market report covers data from the China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and rest of Asia-Pacific..
a